0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze]
RxNorm concept 2561256, branded drug (sbd). Prescribable name: RYLAZE 10 MG in 0.5 ML Injection.
- RxCUI
- 2561256
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2561256 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.5 ML Rylaze 20 MG/ML Injection; Rylaze 10 MG per 0.5 ML Injection
Related concepts
- asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML (SCDC, consists of)
- asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML [Rylaze] (SBDC, consists of)
- Injection (DF, has dose form)
- Rylaze (BN, has ingredient)
- 0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2561256 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2561256 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2561256. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.